RetroVirox Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 6


  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

RetroVirox General Information


Operator of a biotechnology company intended to discover new treatment methods for infectious diseases. The company's services include developing immunomodulators and antivirals for infectious diseases like HIV and Lassa Fever virus, enabling healthcare companies to get new treatment methods for infectious and acute diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 6195 Cornerstone Court East
  • Suite 114
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RetroVirox Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Pre-Clinical Trials
3. Grant 12-Mar-2015 000 Completed Pre-Clinical Trials
2. Grant 01-Jan-2013 $1.63M Completed Startup
1. Seed Round 01-Jan-2008 Completed Startup
To view RetroVirox’s complete valuation and funding history, request access »

RetroVirox Patents

RetroVirox Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220411419-A1 Small molecule modulators of mhc-i Inactive 04-May-2018 0000000000
CA-3099382-A1 Small molecule modulators of mhc-i Inactive 04-May-2018 0000000000

RetroVirox Executive Team (2)

Name Title Board Seat Contact Info
Juan Lama Ph.D Founder, President and Chief Scientific Officer
Cynthia Aguilar Finance and Grant Manager
To view RetroVirox’s complete executive team members history, request access »

RetroVirox Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RetroVirox Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view RetroVirox’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »